Immunotherapy for Head and Neck Cancer

doi:10.1016/j.hoc.2018.12.006

Review

. 2019 Apr;33(2):301-321.

doi: 10.1016/j.hoc.2018.12.006.

Immunotherapy for Head and Neck Cancer

Felix Sim¹, Rom Leidner², Richard Bryan Bell³

Affiliations

¹ Department of Oral and Maxillofacial Surgery, The Royal Melbourne Hospital, 300 Grattan Street, Parkville, Victoria 3050, Australia; Department of Oral and Maxillofacial Surgery, Monash Health, 823 Centre Road, Bentleigh East, Victoria 3165, Australia; Oral and Maxillofacial Surgery Unit, Barwon Health, Ryrie Street & Bellerine Street, Geelong, Victoria 3220, Australia.
² Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Providence Cancer Institute, 4805 Northeast Glisan Street, Suite 2N35, Portland, OR 97213, USA.
³ Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Providence Cancer Institute, 4805 Northeast Glisan Street, Suite 2N35, Portland, OR 97213, USA; Head and Neck Institute, 1849 NW Kearney, Suite 300, Portland, Oregon 97209, USA. Electronic address: richard.bell@providence.org.

PMID: 30833002
DOI: 10.1016/j.hoc.2018.12.006

Review

Immunotherapy for Head and Neck Cancer

Felix Sim et al. Hematol Oncol Clin North Am. 2019 Apr.

. 2019 Apr;33(2):301-321.

doi: 10.1016/j.hoc.2018.12.006.

Authors

Felix Sim¹, Rom Leidner², Richard Bryan Bell³

Affiliations

¹ Department of Oral and Maxillofacial Surgery, The Royal Melbourne Hospital, 300 Grattan Street, Parkville, Victoria 3050, Australia; Department of Oral and Maxillofacial Surgery, Monash Health, 823 Centre Road, Bentleigh East, Victoria 3165, Australia; Oral and Maxillofacial Surgery Unit, Barwon Health, Ryrie Street & Bellerine Street, Geelong, Victoria 3220, Australia.
² Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Providence Cancer Institute, 4805 Northeast Glisan Street, Suite 2N35, Portland, OR 97213, USA.
³ Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Providence Cancer Institute, 4805 Northeast Glisan Street, Suite 2N35, Portland, OR 97213, USA; Head and Neck Institute, 1849 NW Kearney, Suite 300, Portland, Oregon 97209, USA. Electronic address: richard.bell@providence.org.

PMID: 30833002
DOI: 10.1016/j.hoc.2018.12.006

Abstract

The immune system has a vital role in the development, establishment, and progression of head and neck squamous cell carcinoma (HNSCC). Immune evasion of cancer cells leads to progression of HNSCC. An understanding of this mechanism provides the basis for improved therapies and outcomes for patients. Through the tumor's influence on the microenvironment, the immune system can be exploited to promote metastasis, angiogenesis, and growth. This article provides an overview of the interaction between immune infiltrating cells in the tumor microenvironment, and the immunologic principles related to HNSCC. Current immunotherapeutic strategies and emerging results from ongoing clinical trials are presented.

Keywords: Adoptive T-cell transfer; Checkpoint inhibitor; Head and neck cancer; Immunotherapy; Oncolytic virus; Squamous cell carcinoma.

PubMed Disclaimer

Cited by

Exploring the frontiers: tumor immune microenvironment and immunotherapy in head and neck squamous cell carcinoma.
Liu S, Wang R, Fang J. Liu S, et al. Discov Oncol. 2024 Jan 31;15(1):22. doi: 10.1007/s12672-024-00870-z. Discov Oncol. 2024. PMID: 38294629 Free PMC article. Review.
Predictive factors in the treatment of oral squamous cell carcinoma using PD-1/PD-L1 inhibitors.
Gao A, Pan X, Yang X, Lin Z. Gao A, et al. Invest New Drugs. 2021 Aug;39(4):1132-1138. doi: 10.1007/s10637-021-01082-w. Epub 2021 Feb 16. Invest New Drugs. 2021. PMID: 33594603 Review.
T cell effects and mechanisms in immunotherapy of head and neck tumors.
Xiang Y, Gong M, Deng Y, Wang H, Ye D. Xiang Y, et al. Cell Commun Signal. 2023 Mar 5;21(1):49. doi: 10.1186/s12964-023-01070-y. Cell Commun Signal. 2023. PMID: 36872320 Free PMC article. Review.
Understanding the tumor microenvironment in head and neck squamous cell carcinoma.
Rad HS, Shiravand Y, Radfar P, Ladwa R, Perry C, Han X, Warkiani ME, Adams MN, Hughes BG, O'Byrne K, Kulasinghe A. Rad HS, et al. Clin Transl Immunology. 2022 Jun 6;11(6):e1397. doi: 10.1002/cti2.1397. eCollection 2022. Clin Transl Immunology. 2022. PMID: 35686027 Free PMC article. Review.
Preoperative Immunotherapy in the Multidisciplinary Management of Oral Cavity Cancer.
Philips R, Han C, Swendseid B, Curry J, Argiris A, Luginbuhl A, Johnson J. Philips R, et al. Front Oncol. 2021 Jul 1;11:682075. doi: 10.3389/fonc.2021.682075. eCollection 2021. Front Oncol. 2021. PMID: 34277428 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Immunotherapy for Head and Neck Cancer

Affiliations

Immunotherapy for Head and Neck Cancer

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Medical